Brain Health Devices Market Report 2024 (Global Edition)

Global Brain Health Devices Market Report 2024 Market Size Split by Device Type (Magnetic Resonance Imaging, Magneto Encephalogram, Computed Tomography, Transcranial Doppler Device, Others), by Applic...

Brain Health Devices Market Report Description

We have various report editions of Brain Health Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Brain Health Devices Market Insights Video

Competitive Landscape of the Brain Health Devices Market

Key companies drive innovation and market growth in the dynamic brain health devices market. These firms pioneer diagnostic and monitoring technologies that establish industry standards. Their strategic research and development investments advance brain health technology, providing a variety of neurological problem remedies. These industry leaders influence the brain health devices market beyond market share, solidifying its status as a vital healthcare area.

In February 2022, Masimo has received USFDA authorization for its SedLine brain function monitoring system and the SedLine Pediatric EEG Sensor, which are intended for pediatric patients aged 1-17 years. This clearance expands the advantages of SedLine to all patients in the United States who are one year of age or older. (Source: https://investor.masimo.com/news/news-details/2022/Masimo-Announces-FDA-Clearance-of-Pediatric-Indication-for-SedLine-Brain-Function-Monitoring-and-the-SedLine-Pediatric-EEG-Sensor/default.aspx) In November 2022, Neurosteer Inc.'s single-channel EEG brain monitoring platform was FDA-approved. The adaptable system may be utilized in numerous clinical settings with this clearance. The platform monitors brain activity in intensive care units (ICUs) for urgent treatments and detects pre-symptomatic cognitive decline in doctors' offices, including Alzheimer's, Parkinson's, and dementia. It facilitates quick and cost-effective neurodegenerative disease screening in pharmaceutical treatment trials. (Source: https://www.neurologylive.com/view/neurosteer-single-channel-eeg-platform-cleared-fda) In September 2023, NTT Communications Corporation (NTT Com), part of the NTT group that provides ICT solutions and international communications, is testing "Brain Health Check Plus," an AI-based tool to identify early cognitive impairment. On World Alzheimer's Day, September 21, 2023, the pilot began delivering a fee-based navigation service to lessen dementia's effect on people, families, and companies. (Source: https://www.ntt.com/en/about-us/press-releases/news/article/2023/0921.html)

Top Companies Market Share in Brain Health Devices Industry: (In no particular order of Rank)

• Medtronic plc
• Natus Medical Incorporated
• Advanced Brain Monitoring
• Inc.
• ElectroCore LLC
• Neuropace
• Inc.
• Integra LifeSciences Corporation
• Boston Scientific Corporation
• LivaNova PLC
• Masimo Corporation
• Magstim
• Soterix Medical Inc.
• Cadwell Industries
• Inc.
• Cogmedix
• Inc.
• Emotiv
• Compumedics Limited
• NeuroSky
• Mindmaze
• Philips Healthcare
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Brain Health Devices Market

Which Region Dominates the Brain Health Devices Market in 2024?

According to Cognitive Market Research, North America currently dominates the Brain Health Devices market, and the region is expected to have significant growth during the projected period. It is anticipated that the region will have the highest revenue share among other regional markets during the projected period, as it is a prominent center for the mental health devices market. This is primarily due to a convergence of factors that cultivate a robust demand for these technologies.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The region is experiencing a surge in demand for high-quality healthcare, medical tourism, and research activities as a result of the increased government initiatives to raise awareness.

The current report Scope analyzes Brain Health Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Brain Health Devices

According to Cognitive Market Research, the global Brain Health Devices market size was estimated at USD 16251.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 6500.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Brain Health Devices market with a market size of USD 5128.88 million in 2024 and is anticipated to grow at a CAGR of 11.5% during the projected period. The U.S. market's increasing incidence of neurological disorders.
• The Canada Brain Health Devices market had a market share of USD 780.06 million in 2024 and is anticipated to grow at a CAGR of 12.5% during the projected period. Canada’s increasing prevalence of neurological disorders.
• The Mexico Brain Health Devices market is anticipated to see growth at a CAGR of 12.2% during the projected period, with a market size of USD 591.54 million in 2024.

Europe Brain Health Devices

According to Cognitive Market Research, the global Brain Health Devices market size was estimated at USD 16251.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 4875.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2024 to 2031.

• The United Kingdom Brain Health Devices market had a market share of USD 819.06 million in 2024 and is anticipated to grow at a CAGR of 12.8% during the projected period. In the UK, Brain Health Devices sales see an upswing due to the robust regulatory backing for medical innovation.
• The France Brain Health Devices market is anticipated to see growth at a CAGR of 11.2% during the projected period, with a market size of USD 448.53 million in 2024.
• According to Cognitive Market Research, the German Brain Health Devices market size was valued at USD 965.32 million in 2024 and is anticipated to grow at a CAGR of 12.2% during the projected period. In Germany, Brain Health Devices surged due to the increasing investments in medical equipment that are substantial.
• The Italy Brain Health Devices market is anticipated to see growth at a CAGR of 11.4% during the projected period, with a market size of USD 419.28 million in 2024.
• The Russia Brain Health Devices market is anticipated to see growth at a CAGR of 11.0% during the projected period, with a market size of USD 755.68 million in 2024.
• The Spain Brain Health Devices market is anticipated to see growth at a CAGR of 11.1% during the projected period with a market size of USD 399.78 million in 2024
• The Luxembourg Brain Health Devices market is anticipated to see growth at a CAGR of 12.1% during the projected period, with a market size of USD 151.14 million in 2024.
• The Portugal Brain Health Devices market is anticipated to see growth at a CAGR of 11.8% during the projected period, with a market size of USD 102.38 million in 2024.
• The Greece Brain Health Devices market is anticipated to see growth at a CAGR of 12.3% during the projected period, with a market size of USD 58.50 million in 2024.
• The Rest of Europe's Brain Health Devices market is anticipated to see growth at a CAGR of 10.7% during the projected period, with a market size of USD 755.68 million in 2024.

Asia Pacific Brain Health Devices

According to Cognitive Market Research, the global Brain Health Devices market size was estimated at USD 16251.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 3737.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Brain Health Devices market size was valued at USD 1682.0 million in 2024 and is anticipated to grow at a CAGR of 15.0% during the projected period. Brain Health Devices surged in China due to rapid developments in the field of healthcare technology.
• The Japan Brain Health Devices market is anticipated to see growth at a CAGR of 14.0% during the projected period, with a market size of USD 515.81 million in 2024.
• The India Brain Health Devices market had a market share of USD 448.53 million in 2024 and is anticipated to grow at a CAGR of 17.3% during the projected period. India's private firms have made substantial investments in neurology devices.
• The South Korean Brain Health Devices market is anticipated to see growth at a CAGR of 14.6% during the projected period, with a market size of USD 373.78 million in 2024.
• The Australian Brain Health Devices market is anticipated to see growth at a CAGR of 15.2% during the projected period, with a market size of USD 194.36 million in 2024.
• The South East Asia Brain Health Devices market is anticipated to see growth at a CAGR of 16.5% during the projected period, with a market size of USD 257.91 million in 2024.
• The Rest of Asia Pacific Brain Health Devices market is anticipated to see growth at a CAGR of 15.3% during the projected period, with a market size of USD 265.38 million in 2024.

South America Brain Health Devices

According to Cognitive Market Research, the global Brain Health Devices market size was estimated at USD 16251.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 812.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Brain Health Devices market size was valued at USD 347.78 million in 2024 and is anticipated to grow at a CAGR of 13.5% during the projected period. Brain Health Devices flourished in Brazil due to an increase in consumer expenditure on healthcare and disposable income.
• Argentina's Brain Health Devices market had a market share of USD 136.51 million in 2024 and is anticipated to grow at a CAGR of 13.8% during the projected period. Argentina's increase in the research and development of neurotherapies.
• Colombia Brain Health Devices market is anticipated to see growth at a CAGR of 12.7% during the projected period, with a market size of USD 72.32 million in 2024.
• Peru Brain Health Devices market is anticipated to see growth at a CAGR of 13.1% during the projected period, with a market size of USD 66.63 million in 2024.
• Chile Brain Health Devices market is anticipated to see growth at a CAGR of 13.2% during the projected period, with a market size of USD 58.50 million in 2024.
• The Rest of Latin America's Brain Health Devices market is anticipated to see growth at a CAGR of 12.0% during the projected period, with a market size of USD 130.82 million in 2024.

Middle East and Africa Brain Health Devices

According to Cognitive Market Research, the global Brain Health Devices market size was estimated at USD 16251.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 325.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031.

• The GCC Countries Brain Health Devices market is anticipated to see growth at a CAGR of 14.0% during the projected period, with a market size of USD 139.11 million in 2024. Brain Health Devices sales flourish due to the increasing utilization of sophisticated medical technologies.
• The Egypt Brain Health Devices market is anticipated to see growth at a CAGR of 13.5% during the projected period, with a market size of USD 34.13 million in 2024.
• The South Africa Brain Health Devices market is anticipated to see growth at a CAGR of 14.2% during the projected period, with a market size of USD 51.35 million in 2024. Brain Health Devices sales flourished in South Africa due to growing middle-class population.
• The Turkey Brain Health Devices market is anticipated to see growth at a CAGR of 12.7% during the projected period, with a market size of USD 27.95 million in 2024.
• The Nigeria Brain Health Devices market is anticipated to see growth at a CAGR of 12.3% during the projected period, with a market size of USD 34.13 million in 2024.
• The Rest of the MEA Brain Health Devices market is anticipated to see growth at a CAGR of 12.2% during the projected period, with a market size of USD 38.35 million in 2024.

Brain Health Devices Market Analysis

How are Segments Performing in the Global Brain Health Devices Market?

Brain Health Devices Market Device Type Segment Analysis

According to Cognitive Market Research, Magnetic Resonance Imaging Brain Health Devices are likely to dominate the Brain Health Devices Market over the forecast period, due to its ability to detect minor brain changes. MRI produces comprehensive brain pictures using high magnetic fields and radiofrequency pulses to identify anomalies such tumors, strokes, infections, demyelinating illnesses, and others. The non-invasive brain exam is preferable. CT and ultrasound give inferior soft tissue contrast versus MRI. The distinction between grey matter, white matter, and cerebrospinal fluid is clear to doctors. Lesions and abnormalities are better detected on MRI scans.

The Magneto Encephalogram is the fastest-growing segment in the Brain Health Devices Market. This increase is driven by MEG's better spatial accuracy and non-invasive functional brain mapping, which are essential for neurological condition diagnosis and treatment. MEG reliably locates aberrant brain activity, making it useful in epilepsy and brain tumor pre-surgical planning. MEG technology's sensor sensitivity and integration into additional imaging modalities are also driving its acceptance.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Brain Health Devices Industry. Request a Free Sample PDF!

Brain Health Devices Market Application Segment Analysis

According to Cognitive Market Research, the Epilepsy segment holds the largest share of the market. This occurs as a result of a rise in the number of people diagnosed with epilepsy, as well as an increase in the amount of effort being put forward to raise awareness of the illness.

In the Brain Health Devices Market, the Stroke has been expanding at a rapid pace, owing to its substantial global prevalence and disease burden. Brain cells are deprived of oxygen and nutrients when the blood supply to a portion of the brain is disrupted, resulting in the occurrence of a stroke. Impaired functioning and cell death may result from this. A stroke is a prominent cause of long-term disability and is one of the top five causes of mortality on a global scale. In an effort to reduce disability and preserve life, it is imperative to diagnose and treat strokes promptly.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Brain Health Devices End User Segment Analysis

Brain Health Devices Market End User Segment Analysis

According to Cognitive Market Research, The Hospitals segment holds the largest market share. The majority of the development in this segment is due to an increase in the number of patients who are afflicted with a variety of chronic diseases, which has led to an increase in the number of surgical procedures. In comparison to other healthcare settings, hospitals receive a significantly higher volume of patients seeking neurology therapies. This is due to the ease of managing any crises that may arise during surgical procedures and the availability of a diverse array of treatment options.

In the Brain Health Devices market, the rapidly growing sector is the Specialty Clinics. Increased neurological illnesses including epilepsy and Parkinson's because this rise. Complex epilepsy patients get the best medical and surgical care at these hospitals. Numerous neurology centers in advanced nations, increased safety, ease of scheduling, focused clinical staff, enhanced efficiency, and patient preference for minimally invasive medical treatments and the efficacy of these centers are likely to drive growth in the coming years.

• Hospitals
• Specialty Clinics
• Research Institutes
• Home Healthcare
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion